Intelligent Health.tech Issue 05 | Page 7

NEWS

PALO ALTO NETWORKS TO PROTECT HEALTHCARE DEVICES WITH MEDICAL IOT SECURITY

Palo Alto Networks has announced Medical IoT Security – one of the most comprehensive Zero Trust security solutions for medical devices – enabling healthcare organisations to deploy and manage new connected technologies quickly and securely . Zero Trust is a strategic approach to cybersecurity that secures an organisation by eliminating implicit trust by continuously verifying every user and device .

“ The proliferation of connected medical devices in the healthcare industry brings a wealth of benefits , but these devices are often not well secured . For example , according to Unit 42 , an alarming 75 % of smart infusion pumps examined on the networks of hospitals and healthcare organisations had known security gaps ,” said Anand Oswal , Senior Vice President of Products , Network Security at Palo Alto Networks .
“ This makes security devices an attractive target for cyberattackers , potentially exposing patient data and ultimately putting patients at risk .”
While a Zero Trust approach is critical to help protect medical devices against today ' s innovative cyberthreats , it can be hard to implement in practice .
Through automated device discovery , contextual segmentation , least privilege policy recommendations and one-click enforcement of policies , Palo Alto Networks Medical IoT Security delivers a Zero Trust approach in a seamless , simplified manner .
Medical IoT Security also provides best-in-class threat protection through seamless integration with Palo Alto Networks ' cloud-delivered security services , such as Advanced Threat Prevention and Advanced URL Filtering .

SPARTA SCIENCE AWARDED US AIR FORCE SMALL BUSINESS INNOVATION RESEARCH PHASE I CONTRACT

Sparta Science , a developer of a scalable , Machine Learning-based movement health platform , was recently awarded an AFWERX Small Business Innovation Research ( SBIR ) Phase I contract by the United States Air Force to identify early biomarkers of cumulative sub-concussive brain injury . This award is significant because it will allow Sparta to develop the capability to identify objectively when airmen are negatively affected by cumulative exposure to repetitive sub-concussive blasts to quantify the problem and reduce long-term health impacts . will explore opportunities to enhance clinicians ' and practitioners ' abilities to deliver effective movement health guidance at a scale relevant to the USAF .

Under this award , Sparta Science will explore R & D partnerships with Conventional and Special Warfare units and transition / acquisition strategies with programme offices to ensure the successful transition of Sparta ' s subconcussive brain injury identification capabilities . Implementing this technology across the DoD could increase the identification of cumulative sub-concussive brain injury , reduce lost duty days due to TBI and mitigate the long-term effects of these insidious injuries by enabling earlier intervention .
Sparta Science is actively collaborating with the Department of Defense on multiple SBIR Phase I and Phase II projects to improve warfighter readiness by modifying Sparta Science ' s commercially successful movement health intelligence platform to meet several USAF use-cases . These initiatives
www . intelligenthealth . tech 7